Table 2.
II1–5, III1–6 | |||
compound | R5 | R |
AtHPPD inhibition Ki (μM) |
II1 | 2,3,5-trichloro-6-pyridyl | 0.093 ± 0.007 | |
II2 | 2,3,5-trichloro-6-pyridyl | 0.097 ± 0.010 | |
II3 | 2,3,5-trichloro-6-pyridyl | 0.021 ± 0.004 | |
II4 | 2,3,5-trichloro-6-pyridyl | 0.023 ± 0.006 | |
II5 | 2,3,5-trichloro-6-pyridyl | 0.12 ± 0.003 | |
III1 | 2-bromo-2-naphthyl | 2.50 ± 0.011 | |
III2 | 2-bromo-2-naphthyl | 2.2 ± 0.090 | |
III3 | 2-bromo-2-naphthyl | 2.2 ± 0.13 | |
III4 | 2-bromo-2-naphthyl | 2.0 ± 0.012 | |
III5 | 2-nitro-3-pyridyl | 0.23 ± 0.011 | |
III6 | 2-nitro-3-pyridyl | 0.21 ± 0.042 | |
mesotrione | 0.013 ± 0.001 |